Duncan is Head of Innovation Discovery at the University of Manchester Innovation Factory, bringing extensive experience across drug discovery, diagnostics and antimicrobial technologies.

Before joining the Innovation Factory, he was Chief Technical Officer at Microbiosensor, a University spinout developing in vitro diagnostic tests for infection detection.

He previously served as Research Manager and later CEO of Ai2, a spinout focused on commercialising antimicrobial peptides to prevent contact lens–related infections. Earlier in his career, Duncan spent 20 years at AstraZeneca, leading teams identifying new drug targets and managing discovery projects across respiratory, inflammation, infection and diabetes, including work on novel therapeutic modalities.

Duncan holds a PhD in the molecular genetics of antibiotic producing Streptomyces.

Duncan's involvement